Scandion Oncology will develop existing drug to revert resistance

An approved drug may be able to revert anti-cancer drug resistance. Danish Scandion Oncology and researchers from University of Copenhagen and will now initiate development of the drug.

Photo: /Ritzau Scanpix/Morten Dueholm

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles